GABRIELLA MUTSCHLECHNER: Open Payments
NPI 1649862202 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,071 in 44 payments from 13 companies in 2025. Trend: 2023 $669 · 2024 $1,345 · 2025 $1,071
Food & beverage: $1,071
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $253 |
| Lilly USA, LLC | 6 | $224 |
| Corcept Therapeutics | 8 | $147 |
| SI-BONE, INC. | 1 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $84 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| PFIZER INC. | 3 | $66 |
| Axsome Therapeutics, Inc. | 1 | $31 |
| AstraZeneca Pharmaceuticals LP | 1 | $20 |
| GlaxoSmithKline, LLC. | 1 | $19 |
Products named: Korlym, BOTOX, JARDIANCE, VRAYLAR, MOUNJARO, CAPLYTA, REXULTI, NURTEC ODT.
Industry payments across TX — which companies pay providers there.
